On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and Valentina Shakhnovich from Children’s Mercy Hospital in Kansas City and Associate Editor for Clinical and Translational Science discuss reverse translation, the theme of a joint issue of articles recently published in the ASCPT journal family. They discuss the concept of reverse translation as a means to maximize the value of the ever-growing reservoir of real-world data in order to more effectively drive future research using retrospective analysis. Please visit the full joint virtual issue by clicking here.
Episodes: ClinPharmPod
ClinPharmPod is our channel from Clinical Pharmacology & Therapeutics. Join us as we delve into the advances in the nature, action, efficacy, and evaluation of therapeutics in this cross-disciplinary field of experimental and clinical medicine featuring highlighted content from the one of the top journals in clinical pharmacology and therapeutics.
Stuart MacLeod on Improving Medicine Use for Children
In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under 14 years of age reside. You can read more in the June 2017 issue of CPT focused on Drugs for Chirldren.
Listen and subscribe for free on iTunes and Google Play
Marilyn Huestis on Designer Drugs
In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer Drugs.
Listen and subscribe for free on iTunes and Google Play
Marlene Haffner on Orphan Drugs
This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here.
Listen and subscribe for free on iTunes and Google Play
Bernard Vrijens on Dose Individualization
This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here.
Listen and subscribe for free on iTunes and Google Play